Theralase Technologies Inc.: Theralase Commences Collaborative Research with National Microbiology Laboratory for Development of Coronavirus Vaccine
Theralase Technologies Inc.: Theralase Commences Collaborative Research with National Microbiology Laboratory for Development of Coronavirus Vaccine ® Technologies Inc. (" TSXV:TLT)( OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (" PDC") and their associated drug formulations to safely and effectively destroy various cancers, bacteria and viruses, announced today that it has executed a Collaborative Research Agreement (" CRA") with the National Microbiology Laboratory, Public Health Agency of Canada ("...